The human eIF4E:4E-BP2 complex structure for studying hyperphosphorylation

Juan Zeng1, CuiMin Lu1, Xuan Huang1

  • 1School of Biomedical Engineering, Guangdong Medical University, Dongguan 523808, China. azengjuan@gdmu.edu.cn.

Insights

4E-binding proteins (4E-BPs) regulate mRNA translation by competing with eIF4G for eIF4E binding. This study reveals unique interactions of 4E-BP2 with eIF4E, explaining its tumor-suppressive role and providing a structural basis for phosphorylation regulation.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Cancer Research

Background:

  • Cap-dependent mRNA translation is crucial for protein synthesis and often dysregulated in cancers.
  • eIF4E-binding proteins (4E-BPs) act as tumor suppressors by inhibiting translation, but their precise interaction mechanisms with eIF4E remain unclear.
  • Understanding these interactions is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the structural basis of interactions between human eIF4E and the binding motifs of eIF4G and 4E-BPs.
  • To elucidate the role of unique structural features in 4E-BP2 in its competitive advantage over eIF4G.
  • To predict the structure of the full-length human eIF4E:4E-BP2 complex, including phosphorylation sites.

Main Methods:

  • Comparative analysis of canonical (CEBM) and auxiliary (AEBM) eIF4E-binding motifs in eIF4G and 4E-BPs.
  • Molecular modeling and structural prediction of protein complexes.
  • Utilizing previous computational work to predict the eIF4E:4E-BP2 complex structure.

Main Results:

  • The CEBM structures are conserved, but 4E-BP2's extended CEBM (ECEBM) forms a longer helix with unique salt bridges and hydrogen bonds to eIF4E.
  • 4E-BP2's AEBM adopts a protective β-sheet conformation, unlike eIF4G's random coil, shielding hydrophobic residues.
  • A predicted structure of the human eIF4E:4E-BP2 complex reveals differences from the eIF4E:eIF4G complex, offering insights into phosphorylation regulation.

Conclusions:

  • The distinct structural features of 4E-BP2's ECEBM and AEBM contribute to its superior binding affinity to eIF4E.
  • The predicted eIF4E:4E-BP2 complex structure provides a foundation for understanding phosphorylation-mediated regulation of translation inhibition.
  • These findings have implications for cancer therapy by targeting the eIF4E-4E-BP interaction pathway.